Physician

Sameer Gupta, MD, MPH

According to 2025 Medicare claims, Sameer Gupta, MD, MPH (NPI: 1013171420) practices hematology/oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (NPI: 1841226099; TIN: 23-1714249) and primary practice location at 19010-3200. Gupta is affiliated with the Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 813 traditional Medicare patients, billed 544,836 HCPCS/CPT codes, and received $9,215,678 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,113 prescription claims across 435 beneficiaries totaling $9,667,685 in drug costs, led by Revlimid (Lenalidomide). DME data shows 144 claims. Open Payments data shows 196 records totaling $39,186. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,207,362 to $9,215,678. Similarly, Part D prescription costs have risen steadily, from $963,557 to $9,667,685. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $4,043 to $2,534.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	488	341,470	$2,207,362
2016	508	375,564	$3,894,459
2017	526	338,640	$4,438,279
2018	572	357,127	$4,116,085
2019	576	505,705	$6,303,115
2020	571	563,920	$7,631,208
2021	629	528,882	$7,053,265
2022	643	501,040	$6,319,211
2023	666	559,530	$7,666,651
2024	813	544,836	$9,215,678

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	171	1,370	$963,557
2016	192	1,348	$850,379
2017	226	1,635	$951,370
2018	272	1,825	$1,282,303
2019	290	2,386	$2,612,002
2020	328	2,682	$3,983,663
2021	343	2,379	$3,484,454
2022	331	2,510	$4,283,214
2023	359	2,600	$4,987,519
2024	435	3,113	$9,667,685

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	85	$53,577
2016	11	159	$60,601
2017	N/R	148	$35,117
2018	N/R	68	$8,182
2019	N/R	55	$4,820
2020	N/R	225	$19,871
2021	22	293	$18,025
2022	43	261	$9,754
2023	N/R	161	$19,081
2024	N/R	144	$5,722

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	206	457	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	670	1,940	$98
96375	Injection of additional new drug or substance into vein	179	4,444	$12
96372	Injection of drug or substance under skin or into muscle	198	1,187	$11
36415	Insertion of needle into vein for collection of blood sample	212	1,419	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	55	1,540	$1,261,266
Verzenio	Abemaciclib	102	2,842	$1,076,051
Lenalidomide	Lenalidomide	69	1,932	$975,021
Ibrance	Palbociclib	51	1,428	$812,587
Jakafi	Ruxolitinib Phosphate	46	1,380	$653,347

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8700	Temozolomide, oral, 5 mg	N	N/R	30	$2,083
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	12	$1,375
J8521	Capecitabine, oral, 500 mg	N	N/R	36	$1,235
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	45	$652
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	21	$376

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	196	$39,186	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sameer Gupta, MD, MPH?

Tedicare shows public-source Medicare data for Sameer Gupta, MD, MPH (NPI 1013171420), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sameer Gupta, MD, MPH have ACO affiliation data?

Sameer Gupta, MD, MPH is shown with ACO affiliation data for Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to Sameer Gupta, MD, MPH?

Sameer Gupta, MD, MPH is linked to BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (billing NPI 1841226099) in the available physician profile data.

Does Sameer Gupta, MD, MPH have Open Payments data?

Sameer Gupta, MD, MPH has 196 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.